Intellia Therapeutics, Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 42/100
What the filing says
Intellia Therapeutics terminated its lease at 130 Brookline Street, Cambridge (15,169 sq ft, originally expiring May 31, 2031) effective December 31, 2026, paying landlord MIT 130 Brookline Leasehold LLC a termination fee of $3,914,000 ($1,957,000 due July 1, 2026 and $1,957,000 due January 4, 2027). The company vacates the premises 4.5 years early, eliminating all remaining lease obligations after the termination date.
Why this rating
One-time $3.9M charge (~0.45% of $869.5M market cap) for real estate exit. Reduces ongoing operating costs but signals potential contraction or relocation. Moderate impact relative to company size.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.